In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...